GL1X · GenesisL1 explorer

MolNFT v1 · #147123 · protein

Structure of rorgt in complex with a novel inverse agonist.

6E3E · Nuclear receptor ror-gamma: “Structure of rorgt in complex with a novel inverse agonist.”. X-ray diffraction, 2 ligands (HQ7, SO4), 7 pockets (best druggability 0.76). MolNFT v1 #147123 on GenesisL1: 3D structure, binding sites and…

PDB
6E3E
Type
protein
Length
434 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
HQ7, SO4
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNuclear receptor ror-gammaprotein21771% helix, 5% strandP51449

Ligands and binding sites

  • HQ7 · 5-[(5R)-5-[(7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]-5-oxopentanoic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14260.760.8438HQ7
23860.750.8538HQ7
34170.550.7237SO4
4800.390.7816empty
5620.340.7713empty

Interfaces

1 interface between chains.

  • A–B · 187 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 6E3E · Structure of RORgt in complex with a novel inverse agonist. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.